Education
About Us
Working with TipRanks
Follow Us
RDIV - AI Analysis
Top Page
Invesco S&P Ultra Dividend Revenue ETF (RDIV)
Rating:68Neutral
Price Target:
$57.00
Positive Factors
Strong Top Holdings
Several key positions, such as CVS Health and PBF Energy, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Energy, Financials, and Consumer Cyclical, helping to balance risks from sector-specific downturns.
Reasonable Expense Ratio
The fund's expense ratio is relatively low, making it a cost-effective option for investors.
Negative Factors
Over-Concentration in U.S. Market
The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.
Underperforming Holdings
Some top positions, such as Best Buy and Prudential Financial, have lagged in performance, which could drag on the fund's returns.
Heavy Energy Sector Exposure
With over 25% of the portfolio in Energy, the fund is highly sensitive to fluctuations in oil and gas markets.
RDIV vs. SPDR S&P 500 ETF (SPY)
AUM852.64M
RegionNorth America
Expense Ratio0.39%
Beta0.74
IssuerInvesco
Inception DateSep 30, 2013
Dividend Yield3.91%
Asset ClassEquity
Index TrackedS&P 900 Dividend Revenue-Weighted Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume26,381
30 Day Avg. Volume29,274
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
57.57Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering62
RDIV Summary
The Invesco S&P Ultra Dividend Revenue ETF (RDIV) is an investment fund that focuses on U.S. companies offering high dividend payouts, making it a great option for investors seeking income. It follows the S&P 900 Dividend Revenue-Weighted Index, which prioritizes companies with strong revenues and reliable dividends. Some well-known companies in this ETF include CVS Health and Chevron. Investors might consider RDIV for its potential to provide steady income and exposure to diverse sectors like energy, financials, and utilities. However, new investors should note that the ETF’s performance can fluctuate with the overall market and is heavily influenced by dividend-paying companies.
How much will it cost me?The Invesco S&P Ultra Dividend Revenue ETF (RDIV) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on high dividend-paying stocks, requiring more research and strategy compared to passively managed funds.
What would affect this ETF?RDIV's focus on high-dividend U.S. companies across sectors like energy, financials, and utilities could benefit from stable economic growth and favorable interest rate environments, which often support dividend-paying stocks. However, rising interest rates or economic slowdowns could negatively impact dividend payouts and the performance of sectors like consumer cyclical and financials. Additionally, regulatory changes in heavily weighted sectors such as energy and healthcare could pose risks to the ETF's holdings.
RDIV Top 10 Holdings
The RDIV ETF leans heavily into high-yield U.S. equities, with a strong focus on energy and financial sectors, which together make up nearly half of its portfolio. Chevron is steady, supported by robust financials and a recent merger, while HF Sinclair is rising on operational improvements. On the flip side, Prudential Financial and Truist Financial are lagging, weighed down by debt concerns and limited momentum. Meanwhile, Best Buy is showing resilience with strategic initiatives despite mixed sales performance. Overall, the fund’s sector concentration in energy and financials makes it sensitive to macroeconomic shifts.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| PBF Energy | 6.57% | $55.69M | $3.79B | 12.72% | 50 Neutral | |
| CVS Health | 6.54% | $55.45M | $104.26B | 46.13% | 76 Outperform | |
| Best Buy Co | 5.83% | $49.40M | $17.62B | -6.79% | 71 Outperform | |
| Macy's | 5.71% | $48.40M | $5.29B | 26.52% | 58 Neutral | |
| HF Sinclair Corporation | 5.44% | $46.10M | $9.90B | 29.73% | 65 Neutral | |
| US Bancorp | 4.80% | $40.68M | $73.56B | -1.97% | 73 Outperform | |
| Chevron | 4.63% | $39.21M | $315.56B | 3.78% | 73 Outperform | |
| Prudential Financial | 4.55% | $38.55M | $35.71B | -19.01% | 69 Neutral | |
| AT&T | 4.31% | $36.49M | $183.76B | 15.87% | 72 Outperform | |
| Truist Financial | 3.80% | $32.17M | $57.16B | 2.88% | 71 Outperform |
RDIV Technical Analysis
Positive
―
Price Trends
51.69
Positive
49.85
Positive
48.23
Positive
Market Momentum
0.28
Negative
52.31
Neutral
69.78
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RDIV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 51.90, equal to the 50-day MA of 51.69, and equal to the 200-day MA of 48.23, indicating a bullish trend. The MACD of 0.28 indicates Negative momentum. The RSI at 52.31 is Neutral, neither overbought nor oversold. The STOCH value of 69.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RDIV.
RDIV Peer Comparison
Comparison Results
Performance Comparison
RDIV
Invesco S&P Ultra Dividend Revenue ETF
52.13
4.30
8.99%
DIV
Global X SuperDividend US ETF
―
―
―
FDV
Federated Hermes U.S. Strategic Dividend ETF
―
―
―
TPHD
Timothy Plan High Dividend Stock ETF
―
―
―
TBG
TBG Dividend Focus ETF
―
―
―
ELCV
Eventide High Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents